Issue 5, 2026, Issue in Progress

A new method for the synthesis of 6,7-dihydro-5H-pyrrolo[2,1-a][2]benzazepines and 5,6,7,9,10,11-hexahydro-12H-indolo[2,1-a][2]benzazepines and evaluation of their bioactivity

Abstract

This article describes a new method for the synthesis of pyrrolo[2,1-a][2]benzazepine and indolo[2,1-a][2]benzazepine derivatives with different pyrrole fragment structures containing functional groups. The method is based on domino reactions involving the imino-ketone fragment of 1-aroyl-4,5-dihydro-3H-[2]benzazepines and electron-deficient alkenes and alkynes. The anticancer and anti-inflammatory activities of synthesized compounds were evaluated. These compounds displayed significant toxicity to four cancer cell lines (including RD, HCT116, HeLa and A549 ones). Amongst these compounds, 3b–e had the best inhibitory activity against the tested cancer cell lines with IC50 values ranging from 4.52 to 19.97 µM, Notably, compound 3b demonstrated the most potent inhibitory effect on nitric oxide (NO) production, with an IC value of only slightly higher than those of the reference compound L-NMMA. Furthermore, molecular docking studies revealed the important interaction of four compounds 3b–e with residues in the etoposide-binding site of topoisomerase as well.

Graphical abstract: A new method for the synthesis of 6,7-dihydro-5H-pyrrolo[2,1-a][2]benzazepines and 5,6,7,9,10,11-hexahydro-12H-indolo[2,1-a][2]benzazepines and evaluation of their bioactivity

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
21 Nov 2025
Accepted
09 Jan 2026
First published
20 Jan 2026
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2026,16, 4363-4372

A new method for the synthesis of 6,7-dihydro-5H-pyrrolo[2,1-a][2]benzazepines and 5,6,7,9,10,11-hexahydro-12H-indolo[2,1-a][2]benzazepines and evaluation of their bioactivity

A. A. Nevskaya, T. A. Dang Thi, T. N. Borisova, A. A. Titov, L. V. Anikina, E. Yu. Nevskaya, A. V. Varlamov, L. G. Voskressensky and L. T. Anh, RSC Adv., 2026, 16, 4363 DOI: 10.1039/D5RA09014H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements